Brest University Hospital Centre, based in Brest runs: Augustin-Morvan hospital; Cavale Blanche Hospital; Bohars hospital; Carhaix hospital; René-Fortin center; care and rehabilitation centre of Guilers; EHPAD Delcourt-Ponchelet, Keravel, Persivien.

During the past decade, CHRU De Brest conducted 524 clinical trials. In the 10-year time frame, 524 clinical trials started and 13 clinical trials were completed, i.e. on average, 2.5% percent of trials that started reached the finish line to date. In the past 5 years, 255 clinical trials started and 9 clinical trials were completed. i.e. 3.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHRU De Brest" #1 sponsor was "University Hospital, Brest" with 311 trials, followed by "Nantes University Hospital" with 56 trials sponsored, "Rennes University Hospital" with 30 trials sponsored, "University Hospital, Lille" with 12 trials sponsored and "University Hospital, Tours" with 12 trials sponsored. Other sponsors include 245 different institutions and companies that sponsored additional 127 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHRU De Brest" #1 collaborator was "Ministry of Health, France" with 28 trials as a collaborator, "University Hospital, Brest" with 9 trials as a collaborator, "Bayer" with 7 trials as a collaborator, "Rennes University Hospital" with 6 trials as a collaborator and "University Hospital, Angers" with 6 trials as a collaborator. Other collaborators include 341 different institutions and companies that were collaborators in the rest 242 trials.

According to Clinical.Site data, the most researched conditions in "CHRU De Brest" are "Pulmonary Embolism" (15 trials), "Breast Cancer" (10 trials), "Heart Failure" (10 trials), "Non Small Cell Lung Cancer" (7 trials) and "Prostate Cancer" (7 trials). Many other conditions were trialed in "CHRU De Brest" in a lesser frequency.

Most popular intervention types in "CHRU De Brest" are "Other" (161 trials), "Drug" (145 trials), "Device" (74 trials), "Procedure" (65 trials) and "Biological" (23 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Placebos" (5 trials), "Data collection" (4 trials), "Placebo Oral Tablet" (4 trials) and "fluorouracil" (4 trials). Other intervention names were less common.

The vast majority of trials in "CHRU De Brest" are 598 trials for "All" genders, 57 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are 208 active trials in "CHRU De Brest". 14 are not yet recruiting, 156 are recruiting, 37 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 333 completed trials in CHRU De Brest, 1 suspended trials, and 38 terminated clinical trials to date.

Out of the total trials that were conducted in CHRU De Brest, 9 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 95 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 22 trials, and there were also 181 trials that are defined as “Not Applicable".

CHRU De Brest has several departments that took part in Clinical trials: "Hopital Augustin Morvan; Hematologie" - 16 trials, "Hopital Augustin Morvan; Federation De Cancerologie" - 13 trials, "CHU Brest Hopital La Cavale Blanche; Neurologie" - 2 trials, "Hopital La Cavale Blanche; Nephrologie" - 3 trials, "Virologie" - 2 trials, "Hopital Morvan; Oncologie - Radiotherapie" - 2 trials, "Service de cardiologie, CHU Brest" - 2 trials